Boston Scientific 1Q Profit, Sales Rise
April 28 2021 - 07:13AM
Dow Jones News
By Dave Sebastian
Boston Scientific Corp. said its profit rose for the first
quarter as sales increased, including a 10% growth in its
cardiovascular sales.
The Marlborough, Mass.-based medical-products company Wednesday
posted net income of $341 million, compared with $11 million in the
prior year. Earnings were 23 cents a share, compared with a penny a
share in the year-ago period.
Adjusted earnings were 37 cents a share. Analysts polled by
FactSet were looking for 31 cents a share. The company had guided
earnings of 5 cents a share to 11 cents a share, and 28 cents a
share to 34 cents a share on an adjusted basis.
Net sales rose 8.2% to $2.75 billion, ahead of its guidance of a
flat to 6% growth. Analysts were looking for $2.62 billion.
Write to Dave Sebastian at dave.sebastian@wsj.com
(END) Dow Jones Newswires
April 28, 2021 06:58 ET (10:58 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
Boston Scientific (NYSE:BSX)
Historical Stock Chart
From Feb 2024 to Mar 2024
Boston Scientific (NYSE:BSX)
Historical Stock Chart
From Mar 2023 to Mar 2024